Biohub is spearheading a $1.8 billion initiative to develop artificial intelligence models capable of predicting how cells behave, according to The Decoder. This ambitious project is supported by major players including Meta, Google DeepMind, Isomorphic Labs, and the US Department of Energy.

The effort aims to train these AI systems over about a year, bringing together expertise and funding from both the tech and scientific communities. Notably, Meta’s involvement links back to Mark Zuckerberg and Priscilla Chan, highlighting the growing intersection of technology and biology.

For Japanese investors and researchers, this project signals increasing global momentum in AI-driven biotech innovation, an area that could influence future developments in healthcare and pharmaceuticals within Japan’s market.